Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Evans John M. −$1.2M CEO sold 5% of stake
  2. Cavanagh Bethany J −$5K SVP, Finance and Treasurer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A-1 Preferred Stock −1,338,000 0
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A-1 Preferred Stock −1,338,000 0
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A-2 Preferred Stock −2,750,336 0
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A-2 Preferred Stock −2,750,335 0
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series B Preferred Stock −33,184 0
2020-02-10 ARCH Venture Partners IX, LLC 10% owner Conversion · Series B Preferred Stock −33,184 0
2020-02-05 Ciaramella Giuseppe President & CSO Grant or award · Stock Option (Right to Buy) +27,317 23,317
2020-02-05 Ciaramella Giuseppe President & CSO Grant or award · Stock Option (Right to Buy) +12,978 12,978
2020-02-05 Evans John M. CEO Grant or award · Stock Option (Right to Buy) +99,336 99,336
2020-02-05 Evans John M. CEO Grant or award · Stock Option (Right to Buy) +53,964 53,964

Page 32 of 32 · 630 trades